SPRI Clinical Trials Revenue and Competitors

Pittsboro, NC USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • SPRI Clinical Trials's estimated annual revenue is currently $8M per year.(i)
  • SPRI Clinical Trials's estimated revenue per employee is $201,000

Employee Data

  • SPRI Clinical Trials has 40 Employees.(i)
  • SPRI Clinical Trials grew their employee count by 0% last year.

SPRI Clinical Trials's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.8M294%N/AN/A
#2
$3.2M160%N/AN/A
#3
$83.2M4147%N/AN/A
#4
$31M15456%N/AN/A
#5
$66.6M2650%$35MN/A
#6
$10.9M546%N/AN/A
#7
$6.8M34-6%N/AN/A
#8
$165.7M21614%$250.7MN/A
#9
$26.5M132-11%$637.8KN/A
#10
$49.4M2466%N/AN/A
Add Company

What Is SPRI Clinical Trials?

SPRI is fully engaged in its 12th year in the CRO business. Business has been booming and growth in Turkey where we are running an orphan study in Pediatric Patients, Mexico- where we have begun our partnership tied to a clinical site network and in Georgia, where we partnered with one of the top CROs in the industry and led to fast start up, enrollment and quality. Our business in the USA, Ukraine and Russia has also been growing and have been expanding in our therapeutic areas of Cancer, Infectious Disease, Hepatitis and Psychiatry and Neurology Focusing on Global Clinical Operations--we help clients meet the challenges of managing global clinical studies, regardless of size or complexity. SPRI facilitates communication among investigators, sponsors and other parties while never losing focus of specific tasks assigned to us. 

Our positive workplace environment and tremendous growth opportunities make SPRI's staff turnover extraordinarily low. SPRl's management team has years of site level experience and a true understanding of issues such as recruitment, CRF completion and query resolution. 
 The main benefits of working with SPRI are: 
 +96% of studies met or beat enrollment projections +More than 40 years of experience managing trials in New York and an expansion across Eastern and Central Europe expansion in 2004 with focus in Belarus, Georgia, Russia and Ukraine +Network of associates that expands our reach within Europe and Australasia 
 +Low staff turnover 
 +Audits demonstrate commitment to quality 
 +Growth through repeat business and referrals Our quality is so strong that 40% of our work is with and for other CROs- whether we are bringing them coverage in other regions or SPRI runs their trials in our region- it defines our results and why customers choose us.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.7M432%N/A
#2
$13.1M5413%N/A
#3
$16.2M7116%N/A
#4
$56.4M1909%N/A
#5
$35M7680%N/A